CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $263.48M, lower than 95% of all stocks globally
- PositionGross margin is 86.2%, higher than 95% of its Medical Devices peers (median 61%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
263.48MUSDvs all stocks (USD)
Revenue (TTM)
44.88MUSDvs all stocks (USD)
Profit Margin
-60.85%vs Medical Devices peers
Beta
0.4270xvs all stocks
52-Week Change
-6.13%vs all stocks
Market Capitalization
263.48MUSDvs all stocks (USD)
Enterprise Value
245.71MUSDvs all stocks (USD)
Forward P/E
-17.44xvs Medical Devices peers
Price to Sales (TTM)
5.97xvs Medical Devices peers
Price to Book (MRQ)
20.86xvs Medical Devices peers
Enterprise to Revenue
5.47xvs Medical Devices peers
Enterprise to EBITDA
-8.96xvs Medical Devices peers
Gross Margin
86.18%vs Medical Devices peers
Profit Margin
-60.85%vs Medical Devices peers
Operating Margin
-94.52%vs Medical Devices peers
Return on Assets (TTM)
-35.17%vs Medical Devices peers
Return on Equity (TTM)
205.81%vs Medical Devices peers
Revenue (TTM)
44.88MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.02USDUpdated Jul 19, 2026Quarterly Revenue Growth
-2.90%vs Medical Devices peers
Gross Profit (TTM)
38.18MUSDvs all stocks (USD)
EBITDA (TTM)
-27.44MUSDvs all stocks (USD)
Net Income (TTM)
-57.06MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-2.92%vs Medical Devices peers
Operating Cash Flow (TTM)
-19.99MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-9.30MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
45.15MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.96MUSDFY2025 · Dec 31, 2025Gross Profit
38.19MUSDFY2025 · Dec 31, 2025Operating Income
-26.95MUSDvs all stocks (USD)
Pre-tax Income
-39.22MUSDFY2025 · Dec 31, 2025Income Tax Expense
7.00KUSDFY2025 · Dec 31, 2025Net Income
-39.23MUSDFY2025 · Dec 31, 2025EBIT
-33.68MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-26.22MUSDFY2025 · Dec 31, 2025Research & Development
14.96MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
50.17MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
555.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
5.54MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-39.23MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
30.46MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-25.25MUSDFY2025 · Dec 31, 2025Free Cash Flow
-26.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
20.79MUSDFY2025 · Dec 31, 2025Income Tax Paid
16.00KUSDFY2025 · Dec 31, 2025Interest Paid
3.70MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-39.23MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
626.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
9.13MUSDFY2025 · Dec 31, 2025Other Non-cash Items
5.02MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.63MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
837.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-838.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-838.00KUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
10.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-81.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.07MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
29.85MUSDFY2025 · Dec 31, 2025Shares Outstanding
61.41MSharesUpdated Jul 19, 2026Float Shares
49.34MSharesUpdated Jul 19, 2026Shares Short
3.08MSharesUpdated Jul 19, 2026Short Ratio
6.19daysvs all stocks
Short % of Shares Outstanding
6.62%vs all stocks
% Held by Insiders
34.05%vs all stocks
% Held by Institutions
34.59%vs all stocks
Total Cash (MRQ)
56.55MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9210USDUpdated Jul 19, 2026Total Debt (MRQ)
34.49MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
2.69xvs Medical Devices peers
Current Ratio (MRQ)
5.78xvs Medical Devices peers
Book Value per Share (MRQ)
0.2090USDUpdated Jul 19, 2026Total Assets
35.33MUSDvs all stocks (USD)
Total Current Assets
32.24MUSDFY2025 · Dec 31, 2025Total Liabilities
69.19MUSDFY2025 · Dec 31, 2025Total Non-current Assets
3.09MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
57.69MUSDFY2025 · Dec 31, 2025Total Current Liabilities
11.50MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
20.44MUSDFY2025 · Dec 31, 2025Accounts Receivable
6.56MUSDFY2025 · Dec 31, 2025Inventory
3.08MUSDFY2025 · Dec 31, 2025Accounts Payable
3.00MUSDFY2025 · Dec 31, 2025Short-term Debt
167.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
234.00KUSDFY2025 · Dec 31, 2025Long-term Debt
34.27MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
23.42MUSDFY2025 · Dec 31, 2025Common Stock (Book)
4.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-330.58MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-33.86MUSDvs all stocks (USD)
52-Week Low
2.20USDUpdated Jul 19, 202652-Week High
7.95USDUpdated Jul 19, 202652-Week Change
-6.13%vs all stocks
Beta
0.4270xvs all stocks
50-Day MA
3.83USDUpdated Jul 19, 2026200-Day MA
4.79USDUpdated Jul 19, 2026Avg 10-Day Volume
280.30KSharesUpdated Jul 19, 2026Avg 30-Day Volume
432.73KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.42USDUpdated Jul 19, 2026Other Income / Expense
-7.29MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 86.2%, higher than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.86Industry median: 0.61Industry P95: 0.85Peers compared: 102
Operating margin is -94.5%, lower than 95% of its Medical Devices peers (median 8.1%)Significant
Operating margin: -0.95Industry median: 0.08Industry P5: -0.73Peers compared: 102
Return on equity is 205.8%, higher than 95% of its Medical Devices peers (median 3%)Significant
Return on equity: 2.06Industry median: 0.03Industry P95: 0.17Peers compared: 102
Debt-to-equity is 2.69×, higher than 95% of its Medical Devices peers (median 0.11×)Significant
Debt-to-equity: 2.69Industry median: 0.11Industry P95: 1.20Peers compared: 102
Price-to-book is 20.86×, higher than 95% of its Medical Devices peers (median 2.69×)Significant
Price-to-book: 20.86Industry median: 2.69Industry P95: 16.17Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.86Profit Margin: -0.61
Significant cash reserves alongside high leverageNotable
Cash (USD): 56,553,000Total Debt (USD): 34,487,000Debt-to-Equity: 2.69
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $263.48M, lower than 95% of all stocks globallySignificant
Market cap (USD): 263,476,935Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Nucien Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Fischer Medical Ventures Ltd
Tier 1ProductionApproval-Gated PipelineFlowRule
Ginwa Enterprise Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Niagen Bioscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Senseonics Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Entrada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
Opus Genetics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sab Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule